BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23522096)

  • 1. Study of Optimal Replacement of Thyroxine in the ElDerly (SORTED): protocol for a mixed methods feasibility study to assess the clinical utility of lower dose thyroxine in elderly hypothyroid patients: study protocol for a randomized controlled trial.
    Wilkes S; Pearce S; Ryan V; Rapley T; Ingoe L; Razvi S
    Trials; 2013 Mar; 14():83. PubMed ID: 23522096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial.
    Jabbar A; Ingoe L; Pearce S; Zaman A; Razvi S
    Trials; 2015 Mar; 16():115. PubMed ID: 25872532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST).
    Stott DJ; Gussekloo J; Kearney PM; Rodondi N; Westendorp RG; Mooijaart S; Kean S; Quinn TJ; Sattar N; Hendry K; Du Puy R; Den Elzen WP; Poortvliet RK; Smit JW; Jukema JW; Dekkers OM; Blum M; Collet TH; McCarthy V; Hurley C; Byrne S; Browne J; Watt T; Bauer D; Ford I
    BMC Endocr Disord; 2017 Feb; 17(1):6. PubMed ID: 28158982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Optimal Replacement of Thyroxine in the Elderly (SORTED) - results from the feasibility randomised controlled trial.
    Razvi S; Ingoe L; Ryan V; Pearce SH; Wilkes S
    Thyroid Res; 2016; 9():5. PubMed ID: 27766119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1).
    Razvi S; Ryan V; Ingoe L; Pearce SH; Wilkes S
    Eur Thyroid J; 2020 Jan; 9(1):40-48. PubMed ID: 32071901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
    Escobar-Morreale HF; Botella-Carretero JI; Gómez-Bueno M; Galán JM; Barrios V; Sancho J
    Ann Intern Med; 2005 Mar; 142(6):412-24. PubMed ID: 15767619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over.
    Du Puy RS; Postmus I; Stott DJ; Blum MR; Poortvliet RKE; Den Elzen WPJ; Peeters RP; van Munster BC; Wolffenbuttel BHR; Westendorp RGJ; Kearney PM; Ford I; Kean S; Messow CM; Watt T; Jukema JW; Dekkers OM; Smit JWA; Rodondi N; Gussekloo J; Mooijaart SP
    BMC Endocr Disord; 2018 Sep; 18(1):67. PubMed ID: 30231866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-Reported Satisfaction with Thyroid Hormone Replacement Therapy for Subclinical Hypothyroidism in Older Adults: A Pooled Analysis of Individual Participant Data from Two Randomized Controlled Trials.
    Ravensberg J; Poortvliet RKE; Du Puy R; Rodondi N; Blum M; Kearney P; McCarthy VJC; Quinn T; Dekkers O; Jukema W; Mooijaart S; Gussekloo J
    Thyroid; 2024 Jun; 34(6):702-712. PubMed ID: 38661527
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of Levothyroxine Therapy on the Development of Depressive Symptoms in Older Adults With Subclinical Hypothyroidism: An Ancillary Study of a Randomized Clinical Trial.
    Wildisen L; Feller M; Del Giovane C; Moutzouri E; Du Puy RS; Mooijaart SP; Collet TH; Poortvliet RKE; Kearney P; Quinn TJ; Klöppel S; Bauer DC; Peeters RP; Westendorp R; Aujesky D; Gussekloo J; Rodondi N
    JAMA Netw Open; 2021 Feb; 4(2):e2036645. PubMed ID: 33566107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study.
    Holley M; Razvi S; Dew R; Maxwell I; Wilkes S
    Thyroid Res; 2023 Nov; 16(1):43. PubMed ID: 37953303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The associations of polymorphisms of TSH receptor and thyroid hormone receptor genes with L-thyroxine treatment in hypothyroid patients.
    Al-Azzam SI; Alzoubi KH; Khabour O; Al-Azzeh O
    Hormones (Athens); 2014; 13(3):389-97. PubMed ID: 25079464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
    Clyde PW; Harari AE; Getka EJ; Shakir KM
    JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
    Blum MR; Gencer B; Adam L; Feller M; Collet TH; da Costa BR; Moutzouri E; Dopheide J; Depairon M; Sykiotis GP; Kearney P; Gussekloo J; Westendorp R; Stott DJ; Bauer DC; Rodondi N
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2988-2997. PubMed ID: 29846630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O; Auldin MA; Agarwal R; Kieffer V; Robertson C; Falconer Smith J; Levy MJ; Howlett TA
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-Thyroxine Therapy for Older Adults With Subclinical Hypothyroidism and Hypothyroid Symptoms: Secondary Analysis of a Randomized Trial.
    de Montmollin M; Feller M; Beglinger S; McConnachie A; Aujesky D; Collet TH; Ford I; Gussekloo J; Kearney PM; McCarthy VJC; Mooijaart S; Poortvliet RKE; Quinn T; Stott DJ; Watt T; Westendorp R; Rodondi N; Bauer DC
    Ann Intern Med; 2020 Jun; 172(11):709-716. PubMed ID: 32365355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).
    Zhang X; Wang WY; Zhang K; Tian J; Zheng JL; Chen J; An SM; Wang SY; Liu YP; Zhao Y; Wang JJ; Yang M; Tang YD
    Trials; 2019 Feb; 20(1):143. PubMed ID: 30782213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
    Livingston M; Birch K; Guy M; Kane J; Heald AH
    Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
    Kabadi UM
    Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.